- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artrya Ltd (AYA)
Assess today's live Artrya Ltd (AYA) share price, performance and insights using our live Sydney: AYA stock exchange data.
Analyse the historical data and Artrya Ltd share price performance charts on this page. Our technical summary section provides analysis on Artrya share price buy/sell indicators using real-time data (or discuss the Artrya (AYA) stock price today with other investors in the Artrya ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX AYA share price (ISIN: AU0000182412) to enhance your trading decisions with our free investment tools and resources.
What Is the Artrya Ltd Share Price Today?
The Artrya share price today is 3.27.
What Is the Stock Symbol for Artrya Ltd
The stock symbol (or 'ticker') for Artrya Ltd is "AYA."
What Stock Exchange Does Artrya Ltd Trade On?
Artrya Ltd is listed and trades on the Sydney stock exchange.
Is Artrya Ltd a Good Stock to Buy?
Determining whether Artrya Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Artrya Ltd share price performance charts on this page. Our technical summary section provides analysis on Artrya share price buy/sell indicators using real-time data (or discuss the Artrya (AYA) stock price today with other investors in the Artrya ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX AYA share price (ISIN: AU0000182412) to enhance your trading decisions with our free investment tools and resources.
What Is the Artrya Ltd Share Price Today?
The Artrya share price today is 3.27.
What Is the Stock Symbol for Artrya Ltd
The stock symbol (or 'ticker') for Artrya Ltd is "AYA."
What Stock Exchange Does Artrya Ltd Trade On?
Artrya Ltd is listed and trades on the Sydney stock exchange.
Is Artrya Ltd a Good Stock to Buy?
Determining whether Artrya Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Sydney
Currency in AUD
3.27
-0.11(-3.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.06
3.30
52 wk Range
0.56
5.24
AYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.063.30
52 wk Range
0.565.24
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AYA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.62
Upside
+102.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Artrya Company Profile
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
Artrya Ltd Earnings Call Summary for Q2/2026
- Artrya Ltd reported Q2 2026 customer receipts of $60,000, raised AUD 80 million, and maintained AUD 76.5 million in cash reserves despite a 1.27% stock price decline to $3.53.
- The company successfully converted three U.S. foundation partners into full commercial customers and established an on-ground customer success team to strengthen its American market presence.
- Artrya launched the Salix Coronary Plaque module and is targeting FDA clearance for its Flow module by June 2026, aiming to capture a share of 400,000 annual CCTA scans in the U.S.
- Management expects to fully integrate U.S. customers and increase foundation customer engagement by FY27, with SAPPHIRE partners inclusion anticipated by FY28.
- Operating outflows decreased to $5.4 million from $6.1 million in the previous quarter, reflecting improved operational efficiency as the company expands.
Last Updated: 02/02/2026, 00:48
Read Full TranscriptCompare AYA to Peers and Sector
Metrics to compare | AYA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAYAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −31.5x | −5.8x | −0.5x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 24.3x | 1.8x | 2.6x | |
Price / LTM Sales | 18,462.0x | 11.4x | 3.3x | |
Upside (Analyst Target) | 102.4% | 65.6% | 45.7% | |
Fair Value Upside | Unlock | −2.8% | 6.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.62
(+102.45% Upside)
Earnings
Latest Release
Aug 20, 2025
EPS / Forecast
-0.09 / --
Revenue / Forecast
15.00K / --
People Also Watch
FAQ
What Is the Artrya (AYA) Share Price Today?
The live Artrya share price today is 3.27
What Stock Exchange Does Artrya (AYA) Trade On?
Artrya is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Artrya?
The stock symbol (also called a 'ticker') for Artrya is "AYA."
What Is the Current Artrya Market Cap?
As of today, Artrya market capitalisation is 516.93M.
What Is Artrya's (AYA) Earnings Per Share (TTM)?
The Artrya EPS is currently -0.18 (Trailing Twelve Months).
Is AYA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Artrya moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Artrya Stock Split?
Artrya has split 0 times. (See the AYA stock split history page for full effective split date and price information.)
What is the current trading status of Artrya (AYA)?
As of 07 Feb 2026, Artrya (AYA) is trading at a price of 3.27, with a previous close of 3.38. The stock has fluctuated within a day range of 3.06 to 3.30, while its 52-week range spans from 0.56 to 5.24.
What Is Artrya (AYA) Price Target According to Analysts?
The average 12-month price target for Artrya is AUD6.62, with a high estimate of AUD6.62 and a low estimate of AUD6.62. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +102.45% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.